Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted <sup>1</sup>H-NMR Metabolomics

Código QR

Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted <sup>1</sup>H-NMR Metabolomics

Determining biomarkers and better characterizing the biochemical progression of nonalcoholic fatty liver disease (NAFLD) remains a clinical challenge. A targeted <sup>1</sup>H-NMR study of serum, combined with clinical variables, detected and localized biomarkers to stages of NAFLD in mo...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Emma J. Robinson, Matthew C. Taddeo, Xin Chu, Weixing Shi, Craig Wood, Christopher Still, Virginia G. Rovnyak, David Rovnyak
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	nonalcoholic fatty liver disease NAFLD obesity nuclear magnetic resonance NMR metabolomics Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/b969e8e1bbec4e9e88c9cf0348489cde
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

<sup>1</sup>H-NMR Metabolomics as a Tool for Winemaking Monitoring
por: Inès Le Mao, et al.
Publicado: (2021)

Metabolite Profiling of <i>Helichrysum italicum</i> Derived Food Supplements by <sup>1</sup>H-NMR-Based Metabolomics
por: Antonietta Cerulli, et al.
Publicado: (2021)

Metabolic Changes in the Trichomes of <i>Cannabis sativa</i> var. <i>bedrobinol</i> Analyzed by <sup>1</sup>H-NMR-Based Metabolomics
por: Nizar Happyana, et al.
Publicado: (2020)

Biochanin A Regulates Cholesterol Metabolism Further Delays the Progression of Nonalcoholic Fatty Liver Disease
por: Fan Y, et al.
Publicado: (2021)

Probing Hepatic Glucose Metabolism via <sup>13</sup>C NMR Spectroscopy in Perfused Livers—Applications to Drug Development
por: Corin O. Miller, et al.
Publicado: (2021)

Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis
por: Filip R, et al.
Publicado: (2018)

<sup>1</sup>H HR-MAS NMR Based Metabolic Profiling of Lung Cancer Cells with Induced and De-Induced Cisplatin Resistance to Reveal Metabolic Resistance Adaptations
por: Martina Vermathen, et al.
Publicado: (2021)

Predicting Pt-195 NMR Chemical Shift and <sup>1</sup>J(<sup>195</sup>Pt-<sup>31</sup>P) Coupling Constant for Pt(0) Complexes Using the NMR-DKH Basis Sets
por: Joyce H. C. e Silva, et al.
Publicado: (2021)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
por: Apollinariya V. Bogolyubova, et al.
Publicado: (2017)

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
por: Ekaterina E. Mishina, et al.
Publicado: (2017)

Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis
por: Jin Feng, et al.
Publicado: (2021)

MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis
por: Huang J, et al.
Publicado: (2021)

Application of <sup>13</sup>C Quantitative NMR Spectroscopy to Isotopic Analyses for Vanillin Authentication Source
por: Concetta Pironti, et al.
Publicado: (2021)

E-Selectin-Dependent Inflammation and Lipolysis in Adipose Tissue Exacerbate Steatosis-to-NASH Progression via S100A8/9Summary
por: Robim M. Rodrigues, et al.
Publicado: (2022)

Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta‐analysis
por: Shahinul Alam, et al.
Publicado: (2021)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
por: T. E. Promenasheva, et al.
Publicado: (2014)

Analysis of prevalence of risk factor of nonalcoholic fatty liver disease in the Buryat Republic
por: E. G. Naydanova
Publicado: (2015)

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
por: A. V. Bogolyubova, et al.
Publicado: (2019)

The Association Between Different Obesity Phenotypes and Liver Fibrosis Scores in Elderly Individuals with Fatty Liver in Taiwan
por: Lee YS, et al.
Publicado: (2021)

1H -NMR Metabolomics Study of the Effect of Cisplatin and Casiopeina IIgly on MDA-MB-231 Breast Tumor Cells
por: Karen Resendiz-Acevedo, et al.
Publicado: (2021)

Identification and Quantification of Hydrocarbon Functional Groups in Gasoline Using <sup>1</sup>H-NMR Spectroscopy for Property Prediction
por: Abdul Gani Abdul Jameel
Publicado: (2021)

Nonalcoholic fatty liver disease (NAFLD) – a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients
por: Mikolasevic I, et al.
Publicado: (2014)

Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease
por: Na Fei, et al.
Publicado: (2020)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
por: Mao YQ, et al.
Publicado: (2016)

Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of Taiwan
por: Shen HC, et al.
Publicado: (2014)

Sex-Dependent Effects of Eicosapentaenoic Acid on Hepatic Steatosis in UCP1 Knockout Mice
por: Kembra Albracht-Schulte, et al.
Publicado: (2021)

Gender-Specific Metabolomics Approach to Kidney Cancer
por: Stanisław Deja, et al.
Publicado: (2021)

Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial
por: Soleimani D, et al.
Publicado: (2020)

Correlation Between Psoriasis Severity and Nonalcoholic Fatty Liver Disease Degree Measured Using Controlled Attenuation Parameter
por: Gandha N, et al.
Publicado: (2020)

Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease
por: Szanto KB, et al.
Publicado: (2019)

Association Between the Triglyceride–Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study
por: Liu J, et al.
Publicado: (2021)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
por: Gwyneth Shook Ting Soon, et al.
Publicado: (2021)

Quality evaluation of Cabernet Sauvignon wines in different vintages by 1H nuclear magnetic resonance-based metabolomics
por: Xu Shaochen, et al.
Publicado: (2021)

<sup>1</sup>H-NMR Plasma Lipoproteins Profile Analysis Reveals Lipid Metabolism Alterations in HER2-Positive Breast Cancer Patients
por: Giuseppe Corona, et al.
Publicado: (2021)

Estimation of the Prevalence of Nonalcoholic Fatty Liver Disease in an Adult Population in Northern China Using the Data Mining Approach
por: Yang T, et al.
Publicado: (2021)

A Comparative Analysis of Serum Lipids in Patients with Chronic Hepatitis C, Nonalcoholic Fatty Liver Disease and Healthy Controls
por: Valkov I., et al.
Publicado: (2017)

Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism
por: Limin Zhang, et al.
Publicado: (2016)

Mass Spectrometry-Based Metabolomic and Lipidomic Analysis of the Effect of High Fat/High Sugar Diet and Greenshell<sup>TM</sup> Mussel Feeding on Plasma of Ovariectomized Rats
por: Maryam Abshirini, et al.
Publicado: (2021)

Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study
por: Ye Lu, et al.
Publicado: (2021)

Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice
por: Masahiro Matsui, et al.
Publicado: (2021)